Table 2. Prediction of lymph node metastases based on curettage histology, status of L1CAM and ER/PR in curettage specimen in 763 lymph node sampled endometrial cancer patients.
Variable | Na | Uni-variate OR | 95% CI | P | Multivariate OR | 95% CI | P | Sensitivity | Specificity | PPV | NPV |
---|---|---|---|---|---|---|---|---|---|---|---|
Curettage histologyb | |||||||||||
Low risk | 590 | 1 | 1 | ||||||||
High risk | 173 | 3.39 | 2.19–5.23 | <0.001 | 1.94 | 1.16–3.25 | 0.011 | 0.49 | 0.75 | 0.22 | 0.91 |
L1CAM expression | |||||||||||
Low | 681 | 1 | 1 | ||||||||
High | 82 | 4.49 | 2.69–7.50 | <0.001 | 2.51 | 1.41–4.64 | 0.002 | 0.28 | 0.92 | 0.33 | 0.90 |
ER/PR expression | |||||||||||
Normal | 606 | 1 | 1 | ||||||||
Lossc | 157 | 3.26 | 2.10–5.07 | <0.001 | 1.91 | 1.15–3.17 | 0.013 | 0.42 | 0.82 | 0.26 | 0.90 |
Abbreviations: CI=confidence interval; ER=oestrogen receptor; L1CAM=L1 cell adhesion molecule; NPV=negative predictive value; OR=odds ratio; PPV=positive predictive value; PR=progesterone receptor.
Only patients with data available for all variables included in the multivariate logistic regression analysis are included in the univariate analysis (N=763).
Curettage histological classification, low risk (benign, hyperplasia or endometrioid grades 1–2) or high risk (non-endometrioid or endometrioid grade 3).
Patients with double loss of ER/PR expression.